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Progress made in the last two decades in chemical vapour deposition technol-
ogy has enabled the production of inexpensive, high-quality coatings made
from diamond to become a scientific and commercial reality. Two properties
of diamondmake it a highly desirable candidate material for biomedical appli-
cations: first, it is bioinert, meaning that there is minimal immune response
when diamond is implanted into the body, and second, its electrical conduc-
tivity can be altered in a controlled manner, from insulating to near-metallic.
In vitro, diamond can be used as a substrate upon which a range of biological
cells can be cultured. In vivo, diamond thin films have been proposed as coat-
ings for implants and prostheses. Here, we review a large body of data
regarding the use of diamond substrates for in vitro cell culture. We also
detail more recent work exploring diamond-coated implants with the main
targets being bone and neural tissue. We conclude that diamond emerges as
one of the major new biomaterials of the twenty-first century that could
shape the way medical treatment will be performed, especially when invasive
procedures are required.1. Introduction
1.1. Diamond for in vitro and in vivo applications
Since the middle of the twentieth century, in vitro cell-culture techniques have
made great advances in terms of popularity, volume, types of cells to which
they are amenable and downstream applications. To culture living cells in the lab-
oratory, a requirement is a surface that is cheap to manufacture, smooth and
sterilizable, and which minimally affects the normal growth, lifetime and func-
tionality of the chosen cells. The usual substrates of choice are either glass or
an inert plastic, such as polytetrafluoroethylene (PTFE) or tissue-culture-grade
polystyrene (TCP).Many different cell types can be readily and routinely cultured
on such substrates. In vitro cell-culture tests are often used for prospective in vivo
biologically active implant experiments. However, glass, PTFE and TCP differ
significantly from the materials used for fabricating these devices. Maximum
translation from in vitro to in vivo would be obtained if a material equally
suited for both types of applications could be found.
1.2. Diamond films can be produced by chemical vapour deposition
One such substrate material that has recently been gaining in popularity is thin
film diamond. At first glance, diamond may seem like an odd choice from
which to make a biological plate [1,2], as diamond is often perceived as being
used only for jewellery or cutting tools, and overly expensive as a cell-culture sub-
strate. However, in the past 20 years, scientists have perfected a technique known
as chemical vapour deposition (CVD) which allows thin coatings of pure crystal-
line diamond to be deposited onto a range of different materials in a cost-effective
manner [3]. Many companies now supply CVD diamond commercially—indeed,
a freestanding plate of diamond that is 1 cm2 in size by 0.5 mm thick costs only
(a) (c)
(d )
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4 µm
Figure 1. Examples of CVD diamond films patterned using dry etching methods. In (a– e), a variety of different etch processes and mask preparations have been
used to define features with different sizes, shapes and sidewall slopes. Similar dry etch methods can be used to pattern diamond films into almost any desired
shape, including needles, columns, pyramids, etc. Reproduced from [25] under CC-BY licence. (Online version in colour.)
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ing that the plates can be easily cleaned, sterilized and reused.
Moreover, many university research groups and commercial
companies will supply thin coatings (a few mm) of diamond
on a silicon wafer for a fraction of this cost, meaning that the
diamond-coated substrate, far from being unaffordable, is
actually cheaper than many of the reagents needed to grow
the cells!
1.3. Diamond films are biocompatible
But what advantage does diamond offer? The first, and prob-
ably most important benefit is its high biocompatibility, a
property confirmed by nearly a century of studies [4–10].
In early reports, very low toxicity was observed when dia-
mond particles were injected as a suspension into live
animals [5,11,12]. Subsequently, it was established that dia-
mond films as a cell-culture substrate can successfully
support a wide range of adherent cells. In this review, we
will describe in detail the efforts made to optimize the cell-
supportive properties of diamond films by modulating the
crystal granularity, chemical surface termination (with
major implications on hydrophilicity), as well as by pattern-
ing. Another crucial property of diamond is that it is
bioinert, i.e. it does not trigger coagulation or inflammatory
reactions. It should also be noted that, whereas most bioinert
materials show poor cell adherence and vice versa, diamond is
both bioinert and cells readily adhere to it [13–17].
1.4. Diamond films can be electrically conducting
The second advantage is that diamond electrical conductivity
can be controlled by a process called doping (i.e. addition of
tiny amounts of non-carbon elements, acting as electron
donors or acceptors), with the conductivity varying from
highly insulating to near-metallic, depending upon the
amount of dopant added. Indeed, very heavily doped diamond
even exhibits superconductivity at temperatures around 5 K
[18,19]. Elements such as nitrogen and phosphorus have been
used to dope diamond films [20]; however, except in the caseof ultrananocrystalline diamond (UNCD) films (see later) [21],
the resulting conductivity is usually too low to make these
films useful for many electronic applications. The dopant of
choice, therefore, is boron, an element widely used for routine
doping of both silicon and diamond in semiconductor research.
An electrically conducting diamond substrate allows electrical
signals to be passed to and from the cells it supports. This is par-
ticularly useful in the case of neurons, potentially allowing for
direct, two-way communication between supported cells and
the underlying substrate. Electrically conductive diamond
can also be used as an electrochemical electrode which is
particularly useful for biosensor applications [22].
1.5. Diamond can be patterned and its surface
chemically functionalized
A third advantage is that a diamond surface can be readily pat-
terned and/or functionalized to define regions that sustain cell
growth, and regions that do not. A wide range of methods
have been used to pattern diamond, with pattern resolutions
ranging from millimetres to micrometres [23,24]. Diamond
films and freestanding substrates are compatible with the fab-
rication facilities used for making silicon microelectronics, and
hence the standard photolithography and dry etching pro-
cesses used for patterning Si can also be applied to diamond.
Diamond etches readily in oxygen-based plasmas, with gas-
eous CO and CO2 as by-products. The slight complication is
that a two-step etch process must be used [25–27], as the
usual carbon-based photoresists etch away rapidly in oxygen
plasmas, resulting in poor pattern resolution. To solve this, a
thin (100 nm) non-erodible mask material, such as Ni or Al,
is deposited onto the diamond prior to the standard photo-
lithography process, which defines the features, and then this
metal layer is dry etched in a suitable gaseous plasma or wet
etched in acid, stopping at the diamond surface. The exposed
diamond surface can then be etched in an oxygen-based
plasma with the patterned metal acting as a ‘hard-mask’
(figure 1). This metal mask and any remaining photoresist
can finally be removed using a simple acid wash.
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[24]. This uses a high-power laser (usually an excimer or
Nd:YAG) which is focused to a spot on the surface. The energy
density at the laser focus spot is so great that a few atomic
layers of the diamond surface are instantly vaporized. The
amount of material removed with each laser pulse depends
upon the laserpower,wavelengthandspot size.Todefine the fea-
tures, either the substrate ismovedunder the static laser beam, or
the laser beam is scanned across the surface using mirrors.
An alternative patterning strategy, which works well for
deep (greater than 50 mm) features, involves depositing the
diamond film onto a substrate, usually silicon, that has
been pre-patterned using standard etch recipes into features
that are the inverse of those required. This patterned substrate
then acts like a mould, onto which the diamond film is con-
formally deposited. The substrate is then flipped upside
down, and the Si chemically etched off, leaving behind a
freestanding patterned diamond substrate [28].
Rather than pattern the diamond itself, a different approach
is to pattern the layer of protein (usually laminin or poly-L-
lysine) which is often applied to the surface of the diamond
film to promote cell adhesion (see §4.3). This protein layer
can be readily patterned using direct-write focused laser
beams, or it can be stamped onto the surface using a micro-
contact printing method [29]. Cells cultured on this substrate
will generally only survive on the protein-coated areas, and
will die on the uncoated areas.
In terms of functionalizing the diamond surface, a number
of techniques are commonly used [30,31]. Oxidation is done
either by short exposure to an O2 plasma, ozone treatment
(via a high-power UV lamp), or by placing the diamond into
a hot mixture of nitric and sulfuric acid for an hour. These
treatments convert the C–H surface bonds into C–O bonds,
thereby changing the surface properties from hydrophobic
into hydrophilic. This process can be reversed by exposure of
the oxidized film to a H2 plasma. Similarly, exposure to an
NH3 plasma or a halogen-containing (e.g. Cl2, CF4, SF6)
plasma will aminate (–NH2 groups) or halogenate (Cl or F)
the surface, respectively. More complex ‘linker’ molecules can
be tethered to the diamond surface using standard synthetic
chemistry techniques such as Suzuki coupling and UV
photo-addition [32]. The untethered end of these linker mol-
ecules, which are usually terminated with reactive groups
like amines or carboxylic acids, can then be further bonded
to molecules with specific (bio)chemical functionality, such as
proteins, DNA strands, fluorophores and antibodies [33].
Despite all these technological advancements, diamond
has still been rather slow to entermainstreambiomedical appli-
cations. Among potential reasons for this is a lack of awareness
of doctors and medical investigators to regard diamond as a
biomaterial. Often diamond research is presented only in
diamond-themed conferences with little participation from
the medical community. Furthermore, commercially avail-
able diamond films are rarely advertised for their biomedical
applications. Also, medical researchers can be somewhat
conservative when it comes to embracing new unproven
materials, especially ones that are perceived as being niche or
overly expensive. Often, when the awareness exists, doctors
cite diamond’s rigidity as a potential concern, which is a
valid point if diamond were to be used either as large-area
implants, or elongated implants in soft tissues such asmuscles,
but less of an issue if it is to be used as an electrode layer, frac-
tions of a millimetre thick, at the end of a flexible biomaterial.Regardless of the relatively slow uptake, the importance of
diamond in medical research has been underscored in recent
years bymajor collaborative research projects such asNeurocare
(http://neurocare-project.eu/) and DREAMS (http://cordis.
europa.eu/docs/publications/1235/123542961-6_en.pdf) in
Europe, the Bionic Eye (http://www.nvri.org.au/pages/
bionic-eye.html) in Australia and the Argusw II Retinal Prosthe-
sis System developed jointly by Argonne National Labs and
Second Sight Medical Products, Inc. (http://www.second-
sight.com/) in the USA. These national or multinational
projects brought together top institutions from their respective
countries to investigate a potential role for diamond implants
in state-of-the-art treatments designed to improve the quality
of life of otherwise severely impaired patients.
In this review, we shall summarize the current data on the
interaction between diamond and living organisms. We will
provide a brief overview of the many experiments that have
been performed to grow a range of mammalian cells on
CVD diamond substrates and the methods employed. We
will then focus specifically on potential clinical applications
such as in vitro neuronal cells grown on diamond, and dia-
mond brain implants, as well as diamond-based bone and
joint implants. Finally, we shall discuss the advantages and
disadvantages of diamond substrates for the various in vitro
and in vivo applications, and speculate where this technology
may lead.2. Chemical vapour deposition diamond
2.1. The chemical vapour deposition process
Synthesis of diamond films by CVD techniques was first devel-
oped in the late 1980s, and since then it has matured into a
commercial technology, with a number of companies world-
wide (such as Element Six (UK) (http://www.e6cvd.com/),
IIa Technologies (Singapore) (http://2atechnologies.com/),
Fraunhofer IAF (Germany) (http://www.iaf.fraunhofer.de/),
Advanced Diamond Technologies (Illinois, USA) (http://
www.thindiamond.com/) or Diamond Materials (Germany)
(http://www.diamond-materials.com/EN/index.htm), as well
as others in Japan, India, China and Russia, now supplying
CVD diamond films or plates at affordable prices. The CVD
process involves the reaction of amixture of carbon-containing
gas (usuallymethane) and hydrogen in a low-pressure reactor,
followed by the deposition of the carbon in the form of a crys-
talline diamond coating onto a suitable substrate material. The
substrate can be a diamond, inwhich case the CVDprocess will
increase its size. This is the basis for the burgeoning industry in
CVD diamond gemstones destined for the jewellery market
[34]. Alternatively, if the substrate is made from another
material, such as silicon, then the diamond is deposited as a
thin coating or film, which can be nanometres, micrometres
or even millimetres thick, depending upon growth conditions
and time. The diamond coating can remain attached to the sub-
strate, or the substrate can be chemically or mechanically
removed, producing a freestanding diamond plate.
2.2. Types of chemical vapour deposition diamond films
The ultimate material produced by CVD is single-crystal
diamond (SCD), which is almost indistinguishable from
gemstone material. However, the control of the deposition con-
ditions necessary toproduce large areas of SCD isnot yetprecise
(a)
(c) (d )
(b)
(e)
5 µm 5 µm
1 µm
Figure 2. Electron micrograph images of top views of (a) MCD and (b) NCD films. On this magnification scale both SCD and UNCD would appear flat and featureless.
Below are schematic representations of cross sections through (c) MCD with its characteristic columnar structure, (d ) NCD deposited under MCD growth conditions but
for only a short time such that the film remains facetted but is  1 mm thick, and (e) NCD grown with higher methane concentration such that the columnar
structure is lost and the film is smoother with smaller (approx. 100 nm), more rounded grains. On this scale, UNCD would appear very similar, except that the grains
would be even smaller (less than 10 nm), while the films appear smooth (r.m.s. roughness less than 5 nm) with thickness usually less than 1 mm. (Online version
in colour.)
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to areas less than 10 10 mm and have a correspondingly
high price. Currently, the most affordable CVD diamond films
come in the form of a polycrystalline coating, which is a dense
layer made up of many smaller diamond crystallites joined
together by atomic-scale non-diamond (usually graphitic)
grain boundaries. The size of the crystallites and the number
of grain boundaries in the film determine its mechanical and
electronic properties—as well as its bioproperties.2.3. Polycrystalline chemical vapour deposition
diamond films
Polycrystalline CVD diamond films are usually categorized
into three types based on the average size of the crystallites.
First, there is microcrystalline diamond (MCD), where the grain
sizes are approximately 0.5–100 mm in size. These films have
relatively few grain boundaries and exhibit large, faceted crys-
tals arranged in different orientations (figure 2). MCD films
usually exhibit properties that are almost as good as that of
SCD but the large crystallites produce a surface roughness
on the micron scale, which is not amenable to some types of
cell growth. By contrast, nanocrystalline diamond (NCD) films
contain grain sizes in the range of 10–100 nm, and the crystal-
lites are often rounded and much less facetted. Although cells
have been cultured on a variety of diamond crystallite grain
sizes, a number of groups have reported slightly improvedresults on NCD films [14,17,35–37]. Finally, UNCD films
have grain sizes that are less than 10 nm, and grain boundaries
containing amorphous or sp2 carbon that are almost as wide as
the grains. UNCD is thus better described as a composite
material of diamond and amorphous carbon material. Never-
theless, UNCD still retains sufficient diamond-like character
to be useful for many applications, particularly those where a
nanosmooth surface with a low coefficient of friction is impor-
tant, such as mechanical pump seals or coatings for artificial
hip/knee prostheses [38]. It is also the only type of diamond
film where nitrogen, rather than boron, can be used as a
useful dopant, producing highly conducting N-UNCD
material [21].
2.4. Diamond-related materials
There are two other materials related to diamond which
require mentioning. Nanodiamond particles (NDPs), sometimes
also called ‘detonation nanodiamond’, are crystals of diamond
that range in size from a few 100 nm down to 3 nm, and which
can now be bought commercially as powders or as aqueous
suspensions [39]. NDPs are receiving a lot of attention for
their use as fluorescent biomarkers [40] or as vehicles for tar-
geted drug delivery [41] and regenerative medicine [42]. By
dipping a substrate into an NDP suspension (often with the
aid of ultrasonic agitation and/or the use of charged polymers
to help with electrostatic adhesion), a thin, near-continuous
NDP coating forms, which can then be used for cell growth,
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that it is very cheap, and allows bespoke NDP layers to be
fabricated easily without the need for a CVD step. However,
NDPs do not integrate into a compact layer and therefore
they cannot be used to construct flat or three-dimensional elec-
trically conducting tracks. Nevertheless, NDPs could be used
in combination with CVD diamond films as an adhesion-
promoting coating, or to alter the chemical properties of the
diamond surface. There are reports [44] that using an NDP
layer removes the requirements for a protein intermediate
layer (see §4.3) that is usually used when CVD diamond sub-
strates are used for cell growth [45]. Although the focus of
this review is on diamond films and not NDPs, we shall never-
theless discuss NDPs in relation to their bioinert properties.
This is becauseNDPs have a higher risk of being cytotoxic com-
pared with thin films, and also because diamond-coated
implants could release NDPs into the surrounding tissues,
especially if used in areas of high friction, as would be the
case for artificial cartilage surfaces.
The second material of note is diamond-like carbon (DLC),
which should not be confused with CVD diamond. DLC is a
hard, nanosmooth, amorphous carbon material deposited
onto a substrate by physical bombardment, e.g. ion sputtering
[46]. Although it can have up to 50% the properties (e.g. hard-
ness) of diamond, and has a high degree of bioinertness, it is
not crystalline, and may contain significant concentrations of
elements such asH,N andO.DLC is actually a broad term cov-
ering awide range of carbonmaterials composed of a variety of
nanoscale diamond-like and graphite-like regions, and hence a
wide distribution of properties. Many different DLC coatings
have been evaluated as substrates for cell growth, and as
materials for medical biocoatings for over 20 years [47–49],
including protective coatings for hip replacement joints, non-
stick inert coatings for artery stents and coatings for optics.
DLC is a large subject, and not the focus of this review,
which will concentrate on crystalline CVD diamond.3. Diamond biocompatibility
3.1. Biocompatibility of nanodiamond particles
Diamond is one of the most chemically inert materials known.
As a consequence, it is also ‘bioinert’—it does not engage in
biochemical reactions with the internal environment of an
organism, including the human body. The advantage of
this is that implanted in vivo diamond-based devices offer the
prospect of reduced immune response, with little or no inflam-
mation, leading to device lifetimes that can presumably exceed
that of the patient. However, there is a risk that nanosized
NDPs could accumulate inside scavenger cells, which would
be unable to metabolize them, leading to cell toxicity. Perhaps
surprisingly, experiments performed in the first part of the
twentieth century indicated that this might not be a problem.
NDPs injected into natural cavities (e.g. the peritoneal cavity
and lungs) or into the bloodstream of rats did not seem to
have any observable detrimental effects [5,11,12]. More recent
research confirmed that intra-peritoneal injection of fluorescent
NDPs (up to a high dose of 75 mg kg21) also had no observable
toxic effects in rats [6]. Furthermore, in vitro data indicated
that NDPs of various sizes (2–100 nm) can be uptaken by
mammalian cells with minimal cytotoxicity and a low level
of oxidative stress [7,50]. This is in contrast with other types
of nanoparticles, which induce oxidative stress and activatean inflammatory gene profile upon internalization into
human cells [51–53].
An adult organism is endowed with significant robustness
and resistance to extrinsic (bio)chemical threats. This is, how-
ever, not the case of a developing organism, which could
suffermajor damage fromotherwise benign challenges.Never-
theless, when NDPs were administered in ovo no adverse effect
was observed on chicken embryo development [8].3.2. Biocompatibility of diamond films
When considering diamond films and coatings as the outer
layer of implantable devices, a key aspect of biocompatibility
is the potential of the film (or any particulates that may arise
from this as a result of device wear or failure) to activate the
immune response. The first line of defence of the body con-
sists of neutrophils. These cells constantly patrol the inner
linings of the blood vessels in search of intruders. Upon dis-
covering a lesion, they respond by adhering to the site and
secreting granules (degranulation). The chemicals contained
inside the granules activate tissue inflammation, generate
reactive oxygen species to kill or disrupt any potential foreign
organisms, and chemically ‘sound the alarm’, by attracting
more white blood cells (leucocytes) to the affected area. To
test whether this immune response was triggered by the pres-
ence of diamond, test samples made from diamond were
placed in contact with neutrophils and the effects observed.
It was found that adhesion was not increased, degranulation
was not triggered, and reactive oxygen species and chemo-
attractants were not released [2,54,55]. In other words, the
neutrophils were not activated by diamond.
Monocytes, another patrolling white blood cell, migrate to
a site of invasion where they differentiate into macrophages—
specialized scavenger cells, charged with disposing of all
foreign material. Current data suggest that diamond particles
do not activate the monocytes either [15]. Furthermore, macro-
phageswere reported to uptake diamondparticleswithout any
detrimental consequences on their morphology, motility and
viability. By contrast, macrophages exposed to silica crystals
became immobile and died [2,56]. Subsequent studies indi-
cated that diamond particle internalization by macrophages
did not result in an inflammatory response [57].
Blood coagulation is a second (non-immune) branch of the
body’s defence. Its role is twofold: to limit the external loss of
blood after an injury and to limit the internal invasion of
foreign agents. However, in relation to implantable devices,
coagulation can become extremely detrimental as it can isolate
the implant behind a blood clot, induce stenosis (narrowing) of
adjacent blood vessels and trigger hypoxia-activated inflam-
mation. Regrettably, very few studies investigating the role of
crystalline diamond in coagulation have been performed to
date. However, for the very similar material, DLC, it was
observed that fibrinogen (the main component of blood clots)
adsorption, and platelet activation and aggregation are all
low [58,59]. Moreover, subsequent studies showed that this
low thrombogenic activity of DLC is dependent on the concen-
tration of sp3 carbon states (diamond) [60,61]; in other words,
higher diamond-like to graphite-like carbon ratios in the film
result in reduced platelet adhesion. It should also be noted
that the low fibrinogen adsorption is considered crucial for
the low level of neutrophil activation [2]. One of the few studies
[62] investigating crystalline diamond, rather than DLC, found
that platelets could not adhere on diamond, as opposed to
(a)
(c) (d )
(b)
5 µm
10 µm
50 µm
50 µm
Figure 3. Platelet adherence to (a,b) diamond and (c,d ) stainless steel. Very few platelets adhere on diamond, and even those that do so maintain a
round morphology and do not attach and spread on the material. Scale bars (a, c) 50 mm and (b) 5 mm, (d ) 10 mm. Modified from [62], and reproduced
with permission.
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forming blood clots (figure 3). Recently, the development of
artificial cardiovascular devices has been reported using
UNCD coatings [63]. Preliminary studies by the US Company
ADT (http://www.thindiamond.com/) showed that UNCD-
coated valves for an artificial heart eliminated thrombus
formation due to the extreme hydrophobicity of the coatings.
This suggests that UNCD could provide low-wear and
low-friction coatings, as well as being antithrombogenic.
Another important feature is that diamond particles do
not induce haemolysis (the rupturing of red blood cells and
the release of their contents into the surrounding fluids) [4].
This is a fundamental requirement if diamond is ever to be
used as a coating for intravascular devices. While consistent
in vivo research supports DLC’s endothelial biocompatibi-
lity [64–66], the scientific and medical communities are still
waiting for similar data to be reported for diamond.
Diamond doping is an essential feature in terms of bio-
functionality, and boron is one of the most widely used
dopants employed to change its electrical conductivity.
Despite many boron compounds being potentially toxic, a
number of in vivo as well as clinical studies have shown that
boron-doped diamond (BDD) is highly biocompatible and
integrates well with muscle and bone [1,67–69]. In vitro
[14,24] and in vivo [70,71] research indicates that BDD is also
biocompatible for neural tissue, supporting neuronal cell
growth aswell as tissue-electrode integration in the central ner-
vous system (CNS). As described later (§4.2), in vitro BDD is
indistinguishable from undoped diamond in supporting
human neuronal cell cultures, even when cells are challenged
with an oxidative insult [17]. Together, these results suggest
that the boron atoms are locked into the diamond lattice and
cannot leach out to affect nearby cells adversely, although
long-term studies need to be performed to confirm if this
remains true over periods of years or decades.3.3. Limits of biocompatibility and caveats
Althoughdiamond is bioinert, there are limits to its biocompat-
ibility, at least in the case of nanoparticles. At very high
concentrations (over 200 mg ml21) NDPs were found to inhibit
macrophage metabolic activity and proliferation rate [57]. Fur-
thermore, high concentrations of NDPs were found to be toxic
to aquatic life [72]. Interestingly, mammalian cells tolerate at
least one order of magnitude more concentrated solutions of
NDPs compared to aquatic crustaceans.
An interesting exception to diamond’s general biocompat-
ibility is its reported antibacterial properties. Mechanistic
studies have found that different bacterial species show maxi-
mum sensitivity at particular NDP sizes [73], leading to the
inference that specific interaction between the diamond nano-
particle and the bacterial wall are responsible for this effect.
Other groups noted a correlation between NDP’s surface
termination and antimicrobial activity, with maximum
effect observed for partially oxidized and negatively charged
surfaces [74]. Diamond films have also shown bactericidal
properties, especially when they are hydrogen-terminated
and coated onto surfaces consisting of nanostructured needles,
such as black silicon [75].
Collectively, these data confirm diamond’s high biocom-
patibility and low cytotoxicity. They point towards the
absence or very low level of inflammation and coagulation.
As predicted, cellular accumulation of non-degradable
particles can have a detrimental effect, which is dose-
dependent. However, in the case of diamond, any toxicity
can only be observed at significantly high doses, well above
what would be necessary for medical treatments or in-
vestigations. Furthermore, the vast majority of medical, or
medical-research-related procedures involve non-particle,
macroscopic diamond devices for which no toxicity has
been reported so far (see §4.1). Nevertheless, data from
metal alloy and ceramic orthopaedic implants have raised
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particles, especially when significant mechanical wear is
involved. In other materials, for instance titanium dioxide
nanoparticles, an increase in reactive oxygen species for-
mation has been observed, along with double-strand DNA
breaking, inducing cell-cycle arrest [76]. This may partly be
due to the fact that metallic, and to a lesser extent, ceramic
nanoparticles are genotoxic, inducing irreversible DNA
damage [77]. Cases of tissue necrosis produced as a conse-
quence of such nanoparticle debris have also been reported
[78]. With this in mind, a recent study compared UNCD par-
ticles with TiO2 particles in rat tissues. TiO2 particles induced
necrosis and cell membrane damage accompanied by gener-
ation of reactive oxygen species both in lung and liver tissue.
Conversely, none of these effects were observed in the case of
UNCD nanoparticles [79].
It should be noted that, while diamond debris, most prob-
ably composed of NDPs, can be expected to be less genotoxic
than metal and ceramic particles, this still needs to be accu-
rately assessed by future studies. Notably, studies of DNA
damage in human tissues are lacking. In embryonic stem
cells, NDPs increased the expression level of DNA repair pro-
teins (indicative of reversible DNA damage). This effect was
more pronounced for oxidized NDPs, while being lower for
all diamond samples tested compared with multiwalled
carbon nanotubes [80]. Furthermore, the level of particle
release from diamond implants has not been assessed yet,
and this could be presumed to have the highest significance
for orthopaedic applications.4. Diamond as a substrate for cell culture and
biomedical implants
Although diamond biocompatibility has been known for a
long time, it was not until 1991 that a diamond-like material,
in this case DLC, was used as a substrate for in vitro culture of
mammalian cells (mouse fibroblasts and macrophages) [81].
More recently, crystalline diamond started to be considered,
and in the last two decades many types of adherent cells
have been successfully cultured on this substrate. These
include mesenchymal stem cells [82,83], dental stem cells
[84], cardiomyocytes (cardiac muscle cells) [85], neuronal
stem cells [14,86–88], human-induced pluripotent stem
cells (IPS) and IPS-derived neuronal progenitors [17], various
types of neurons [24,29,43–45,89–91], osteoblasts [37,67,92–
97], fibroblasts [16,89,98], macrophages [94,99,100] and
epithelial cells [101,102]. While there is no question about
the value of diamond as a culture substrate for adherent
cells (in fact there is no cell type grown on any other material
that cannot be cultured also on diamond), some controversies
have arisen regarding the optimal culture conditions on
diamond. These will be detailed in §4.2–4.4.
4.1. Diamond versus other biofriendly materials as a
cell culture substrate
The first questionwhich faced diamond researcherswas: is dia-
mond really superior to other routinely used substrates, or is it
just another material on which cells can grow? It should be
noted that because the procedures required for in vitro cell
culture have been optimized for many decades on standard
materials, any further improvements would probably besubtle. Even so, the value of diamond was readily apparent.
When osteoblast (bone cells) and endothelial cells were cul-
tured in vitro, they displayed similar high attachment and
survival rates on plastic, glass and diamond substrates, but
not on silicon [37]. Furthermore, cultured macrophages down-
regulated inflammatory cytokines on diamond compared to
TCP [96], indicating that a diamond implant would activate
the immune response to a lesser extent compared with other
materials. Recent research seems to validate this claim, with
experiments showing that UNCD-coated dental-type implants
that were implanted in vivo in rat bones exhibited excellent
osteointegrationwith no inflammatory response [103]. Further-
more, for a range of cell lines (epithelial and fibroblastic),
diamond was found to be superior to silicon and platinum
when the cell number, total cell area and cell spreading were
quantified [104]. Direct comparison experiments showed
that mouse fibroblasts also attached and proliferated signifi-
cantly better on diamond compared to quartz [83], human
epithelial cells adhered better on diamond versus glass
[101,102], and neural stem cells proliferated and differentiated
better on diamond versus TCP [86]. Other carbon-based
materials, such as fullerene, carbon nanotubes and graphene,
were also able to support the adhesion and growth of osteo-
blast and mesenchymal stem cells, and could support
osteogenic differentiation without inducing DNA damage. In
each case, diamond films and NDP had similar or superior
cell-supportive properties [105].
4.2. Diamond surface characteristics
4.2.1. Surface termination
Laboratory-grown CVD diamond is available with various sur-
face terminations: hydrogenated, where the surface is covered
with C–H bonds, and oxygenated, where the surface contains
mainly carbon–oxygen bonds in a mixture of forms, such as
ether (C–O–C), carbonyl (C¼O) or hydroxyl (C–OH) groups
[106].O termination improves thehydrophilicityof thediamond
surface and therefore is considered likely to enhance biocom-
patibility. Indeed, several studies have showed improved
wettability on O-terminated compared with H-terminated
UNCD, followed by superior cellular adherence and survival
[101,102,107]. For instance, optimal adherence of human epi-
thelial cells was found on oxygenated diamond surfaces,
although pretreatment of the surface by protein adsorptionmiti-
gated the difference between O- and H-terminated surfaces
[101,102]. For osteoblasts, the differencewas somarked that pat-
terned cell growth could be achieved simply by varying the type
of surface termination across the diamond [95]. In a different
study, it was found that O-terminated diamond supported the
formation of bone extracellular matrix, with increased levels of
calciumandphosphorus [84]. Furthermore, cellmorphology fol-
lowed theO-terminated region architecture. However, in at least
one study, contrary results were reported. For the purpose of
creating a wear-resistant bone prosthesis, researchers coated
polished titanium with diamond to create a smooth surface,
and then differentiatedmesenchymal stem cells into osteoblasts.
Here, robust cell adhesion and proliferation was found only on
H-terminated diamond [107].
Nevertheless, on numerous other studies, O termination
supported better biological applications. For example, adher-
ence forces were measured for human fibroblasts on diamond
and were found to increase by several times when the surface
was modified from H to O termination [16]. Moreover, O
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morphogenic protein-2 (BMP2) adsorption, which promotes
bone differentiation [92]. Similarly, neuronal cells could
be successfully cultured on both H- and O-terminated
surfaces, but a small increase in cell number was observed
for O-terminated diamond [24]. One study found that
O termination promotes oligodendrocyte differentiation with-
out affecting neuronal differentiation [86]. Interestingly, for
epithelial cell culture no phenotypical differences were found
to be dependent on the type of diamond termination [101].
Although this could be a cell-type-specific phenomenon, more
work is needed to establish a clear relation between diamond
surface termination and differentiation biases.
H- or O-terminated laboratory-grown diamond can be
further treated to alter the surface termination. Heating the
sample in an atmosphere of the appropriate gases (e.g. Cl2,
F2) allows the diamond surface to become Cl- or F-terminated
[108,109]. This can also be done with plasma treatments using
gasmixtures containing CF4, CCl4 orNH3 [110–112]. The latter
produced aminated (NH2-terminations) diamond films, which
may be candidates for later amide linkages to proteins or
other biomolecules. Another common surface functionaliza-
tion method is to use UV light along with a linker molecule
containing a double bond at one end and a reactive group at
the other. The UV radiation interacts with the double bond,
which then displaces a surface hydrogen, resulting in the
molecule being tethered to the diamond substrate by a covalent
C–Cbond. The reactive group (OH,NH2, etc.) at the free end of
the molecule is then available for subsequent reactions [30].
Although many of these surface terminations have been inves-
tigated for their utility in electrochemistry or to attach
biomolecules [33], only H- and O-terminated diamond have
so far been used for cell culturing.
Finally, a recent study reported cell-specific preferences
dependent on the sterilizationmethod. It is presumed that var-
ious sterilization approaches can influence the type of diamond
termination; and because the main goal of diamond is for it to
be used in implantable devices, which require sterilization, this
is highly relevant. The study found that cell density for cells
cultured on diamond was maximal for samples sterilized by
methods that increased hydrophilicity and that cortical neur-
ons, one of the key target cells for brain implants, preferred
autoclaved diamond [89].4.2.2. Surface topography
It is known that surface topography can significantly influ-
ence the differentiation and survival rates of various cells
attached to it. For instance, it has been shown that mesen-
chymal stem cells can be stimulated to produce bone matrix
simply by the nanoscale patterning of the polymethylmetha-
crylate (PMMA) substrate, even in the absence of osteogenic
supplements [113]. The results were comparable with those
from cells grown on a smooth PMMA surface cultured with
standard osteogenic supplements. Furthermore, neural stem
cells differentiated better, but proliferated less, on micro-
patterned silicon versus flat Si surfaces, and these processes
weredependentonmitogen-activatedproteinkinase (MAPK)sig-
nalling [114]. In the case of diamond, discrete topography can
be produced by various methods, including controlling the
size of the crystals in the polycrystalline structure by varying
the CVD gases and conditions, and modifying the roughness
of the wafer on which the diamond film is deposited. When itcomes to cell preferences for themorphologyof the polycrystal-
line diamond (PCD) surface, apparently smaller is better.
Fibroblasts, osteoblasts and neural cancer cell lines attached,
proliferated and had enhanced cellular functions on NCD
compared with MCD [16,37], and on NCD deposited on low-
roughness substrates compared with that on high-roughness
substrates [70]. In the case of human neural progenitors, opti-
mal cell support was provided by the MCD structure with
the smallest crystals (up to 1 mm) [17]. These findingswere con-
firmed in a different study [14], where NCD crystallites were
grown on microstructured carbon nanotubes (with the dia-
mond crystals replicating the underlying microstructure). In
this case also, optimal support for neuronal progenitors was
observed for 1-mm-scale diamond structures. Nanoscale topo-
graphy on an NCD surface was also reported to promote
superior osteoblast differentiation compared with that seen
on TCP [115]. Another study by Tong et al. [116] concluded
that diamond surface roughness was critical for growth of
healthy rat cortical neurons, with the best results observed
on surfaces with a roughness of about 20 nm. These authors
also suggest that there may be a narrow window of surface
roughness for optimum neuronal adhesion.
Despite the variation in the reports, the consensus seems
to be that, in general, cells prefer to grow on diamond surface
structures and morphologies with sizes of the order of
100 nm to 1 mm. It is very likely that future research will
bring critical insights into the mechanism by which topogra-
phy influences cellular behaviour. Diamond will no doubt
have an important role to play in this research due to the
ease by which it can be patterned.4.3. Diamond protein coating
A protein coating, acting as a bioactive interface ontowhich the
cells can attach with their own matrix-anchoring proteins,
as they would in a living tissue, is commonly used when
mammalian cells are cultured on an artificial substrate. The
requirement for this protein layer, as well as the specific protein
formulation used, is cell-type dependent. An apparent reduced
requirement for this protein layer was observed for various cel-
lular applications employing diamondmaterials. This led to an
interesting debate on whether a protein coating is necessary at
all when diamond is used as a substrate. First, it was observed
that human fibroblasts [98] and mouse hippocampal neurons
[90] can be cultured on nanodiamond films without protein
coating. This observation is significant in the context that fibro-
blasts can routinely be cultured without a protein coating on
TCP but not on standard glass, while neurons require a coating
on both.While these ‘protein free’ culturemethods on diamond
have not been universally accepted, Thalhammer et al. [44]
reported superior adhesion of neurons on various inorganic
substrates coated with protein-free NDPs. These reports have
subsequently been disputed by Ojovan et al. [45], who
suggested that the previous findings may have been con-
founded by adsorption onto the diamond substrate of other
proteins present in the culture media used to sustain the
cells. As all media formulations used to culture neurons con-
tain a proteic component, it is very likely that future studies
will face significant challenges in accurately delineating the
need for an external protein interface between diamond
and neurons.
Finally, it should be noted that while some groups adopt a
minimalistic approach, trying to reduce or eliminate the
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Figure 4. Images showing that artificial body fluids form spontaneous apatite deposits after several days in contact with various substrates. After the first day, only
a thin deposit formed on silicon, which subsequently peeled off. By contrast, with UNCD and MCD (labelled PCD in the figure) strong deposits were formed on the
diamond surface which survived for 14 days. Reproduced with permission from [120]. (Online version in colour.)
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readily adsorb protein. Thus, osteogenic differentiation could
be enhanced by adsorbing BMP2 on diamond prior to cell cul-
ture [92,117,118], while in a different study, researchers were
able to inhibit an inflammatory response in macrophages by
pretreating diamond with collagen and dexamethasone [99].4.4. Diamond for bone repair
Bone was one of the first target tissues for which a diamond
implant was considered. There is significant scope in coating
classical joint and bone implants with crystalline diamond for
the purpose of increasing biocompatibility and adhesion, and
reducing adverse reactivity, inflammation, erosion and release
of metal nanoparticles into the bloodstream. The challenge
here is to optimize the CVD process on standard implant
alloys, as often the diamond deposition process is poor on
metals. Significant progress has been made for deposition on
titanium, cobalt–chromium and even steel substrates (see the
review by Catledge et al. [119]). Early reports have been very
encouraging, as researchers found that coating titanium alloys
withdiamond films increased erosion resistancewhile providing
excellent biocompatibility [67]. This observed biocompatibility
was later confirmed when fibroblast cell lines and human
bone-marrow cells grown ondiamonddisplayed superior viabi-
lity, proliferation, alkaline phosphatase (ALP) activity and
extracellular matrix mineralization and deposition, compared
to those grown on TCP [37,96]. Similarly, in an elegant exper-
iment, silicon and crystalline diamond were placed in contact
with ‘simulated body fluid’ for up to 14 days, and the authors
observed superior spontaneous deposition of apatite (a precur-
sor of hydroxyapatite—the major component of bone matrix)
on NCD [120] (figure 4). Consistent with previous reports,
increased proliferation and superior bone differentiation was
observed for NCD versus MCD [97], and superior osteoblast
function (including collagen production, calcium deposition
and ALP activity) was observed for O termination compared
toH termination [84,121]. Furthermore, osteoblasts could be pat-
terned by selective O andH termination of the diamond surface,with the cells colonizingpreferentially theO-terminated regions,
while the H-terminated regions could only support cellular
growth when cells were seeded at high densities [95]. In a simi-
lar study, cells preferentially arranged themselves on the
O-terminated surface [84].
Interestingly, when BDD was used, differences could
be observed for bone differentiation compared to undoped dia-
mond. For instance, one study reported superior cell adhesion
and improved collagen and vinculin production for osteoblasts
plated on diamond with moderate levels of boron doping,
compared both with heavily doped and undoped diamond
[93]. In a recent study, increased hydroxyapatite deposition
was observed on BDD, and the authors speculated that this
might be connected to electrical conductivity [122]. Further-
more, in vivo studies reported that diamond-coated implants
showed high biocompatibility, good osteointegration and
an increased ability to promote bone growth compared with
standard surgical materials [1,68].
Notably, diamond can be functionalized by simple adsorp-
tion of bioactive reagents, which can then induce a biological
response. For example, NCD functionalized by BMP2 (an indu-
cer of osteogenic differentiation) activated the expression of
osteoblast markers in human mesenchymal cells, indicating
that BMP2 is functional when adsorbed onto diamond. Fur-
thermore, reports of NDPs functionalized with angiotensin
(a factor that stimulates new blood vessel generation) suggest
they could be used to promote repair of damaged or degraded
bone [92,117,123].
Together, these reports establish diamond as a strong
material candidate for bone repair, and it is likely that
dental implants will lead the front of innovation here [103].
However, for the more challenging (and maybe even more
significant) joint repair, more research involving cartilage
cells and tissue is still required.4.5. Diamond for brain research
As described above, mammalian neurons, including human
ones, can be successfully cultured on diamond substrates.
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Figure 5. (a) Fluorescence microscopy of human cortical neurons plated on BDD or undoped diamond and challenged with H2O2, an oxidative stress inducer. The
blue regions show cells stained with Hoecsht stain and identify the cell nuclei, while the red regions are stained with cleaved caspase 3, a marker of apoptosis (cell
death). Scale bars, 25 mm. (b) Quantification of cells stained for cleaved caspase 3. Error bars ¼ standard error of the mean, ***p, 0.001 (between H2O2 chal-
lenged and unchallenged samples). The bar-chart indicates that BDD shows similar biocompatibility to undoped diamond. Even when challenged with oxidative
stress, the cellular response is indistinguishable between the two substrates. Thus, the presence of B in the diamond appears to be non-toxic as far as cell growth is
concerned. Reproduced from [17] under CC-BY licence. (Online version in colour.)
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Figure 6. Patterned artificial neuronal networks, following a pre-stamped laminin grid on a diamond substrate. Reproduced with permission from [29].
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been investigated on undoped diamond and BDD, the latter of
which can function as an electrical conductor. Importantly,
those two diamond-basedmaterials were shown to have indis-
tinguishable biocompatibility in neuronal cultures (figure 5)
[14,17,71,93,124]. A major breakthrough was achieved when
human cortical neurons were cultured long term (over 90
days) on diamond substrates, with cells showing phenotypi-
cally mature synapses [17]. This is essential both for
prospective studies envisaging brain implants (which must
remain functional for many years in vivo), as well as for per-
forming complex studies on artificial neuronal networks
in vitro.
Progress in investigations of artificial neuronal networks
has been made recently by various studies showing directed
neuronal growth on diamond, where the neurons have been
‘persuaded’ to grow preferentially in certain areas. These pat-
terning studies are especially encouraging, considering that a
range of different methods have proved effective. Thus, neur-
ons have been patterned by contact micro-printing [29] as
shown in figure 6, inkjet and laser patterning [24], selective
seeding of NDPs [43] and diamond deposition on patterned
carbon nanotubes [14]. Further studies showed that neuronal
growth on various diamond and DLC substrates can bemanipulated by a combination of laminin coating and surface
termination [125–127]. Similarly, neuroblastoma cells have
also been preferentially grown on UNCD patterned with
O, F or H terminations, and this may lead to new routes to
studying neuronal cancer [128].
Electrical activity of cultured neurons on diamond was
demonstrated by the patch-clamping technique [17,44]. In a
similar way, the signalling activity of cromaffin cells could
be measured through a diamond electrode [129]. Although
cromaffin cells are not neurons, they share structural simi-
larities with sympathetic neurons, importantly sending their
signals to the CNS via neurotransmitters released through
synaptic vesicles. Thus, the measured activity of cromaffin
cells can be equated to neuronal activity. Both these examples
show that neurons and neuron-like cells cultured on diamond
in vitro remain alive and healthy, and crucially are able to
function while sitting on a diamond plate in a cell-culture
dish. It is perhaps worth noting that cellular electrical signals
can also be recorded on BDD electrodes from non-neural
cells, such as cardiomyocytes [85], thus expanding the
range of potential applications for these types of electrodes.
The ultimate goal of diamond biomedical research has
always been the production of safe and reliable neural implants,
and it is only in the last few years that scientific publications on
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Figure 7. A patient treated for tremors using a BDD probe. (a) Brain computer tomography scan showing the predicted implant trajectory, (b) macroscopic image of
the surgical lead and diamond probe, (c) surgical frame stabilizer, (d,e) accelerometry plots of the affected hand before and after the implant, showing decreased
tremor. Reproduced from [135] under CC-BY licence. (Online version in colour.)
rsif.royalsocietypublishing.org
J.R.Soc.Interface
14:20170382
11
 on September 25, 2017http://rsif.royalsocietypublishing.org/Downloaded from this topic have started to appear. An excellent recent review of
diamond for neuronal interfacing is available in [69]. The key
point is whether diamond implants cause less inflammation
and scarring than conventional materials, and reduce the for-
mation of fibrotic capsules—a natural defence mechanism
against foreign bodies, which risks electrically insulating the
probe from its intended target. Some early evidence for this
came when NCD implants placed on the retina of rabbits
were reported to be well tolerated with minimal inflammation
[10].More recently, it was shown that fibrotic capsule formation
and tissue reaction both decreased in the case of implants
coated in NCD compared to ones made from medical-grade
titanium or silicon [100]. Similar results were obtained when
BDD and nitrogen-doped diamond (NDD) were used, with
reduced fibrosis as well as reduced acute and chronic inflam-
matory response compared to silicone [69]. In addition,
another recent study reported further reduction in encapsulation
and inflammation for BDD compared to undoped diamond
[124], although these latter findings await confirmation.
When diamond functionality was tested, ganglion cells
from explanted rat retina could be stimulated through an
NDD electrode, as shown by the action potentials measured
via patch clamping [130]. Subsequently, two methods have
been proposed to produce diamond-only electrode arrays for
retinal prostheses [131,132], and it is conceivable that the
same technology could be applied for stimulating other parts
of the CNS. Furthermore, low impedance, low background
noise and a large potential window have been reported for
BDD electrodes. In one of the oldest studies of this type, BDD
was implanted in the auditory cortex of a live guinea pig,and neuronal sound-dependent stimulations were recorded
[133]. Similarly, UNCD thin film-covered microchips were
successfully implanted on the retina of rabbits [10]. More
recently, BDD was used to record the local field potential
from whole-embryo preparations of mouse hind-brain and
spinal cord [134]. Furthermore, when BDD electrodes were
implanted in a rat cortex, it was shown that they generated
reduced magnetic resonance imaging (MRI) interference com-
pared to metal electrodes [71]. This offers the exciting prospect
of usingMRI as a tool to position diamond implantsmore accu-
rately in sensitive locations, such as the brain, or to use
dynamic MRI to visualize the effects of neural stimulation
via the implant in real time—both of which are very difficult
to achieve with metal implants. Recently, BDD electrodes
have been used for deep brain stimulation, by implantation
in the thalamus of patients suffering from essential tremor
(figure 7) [135]. A similar procedure could be used to treat
Parkinson’s-related tremor.5. Conclusion
The development of CVD technology in the past two decades
has opened the door for the use of crystalline diamond films
and nanoparticles for a range of biomedical applications. Of
note is the ability to control material characteristics, such as
electrical conductivity (through boron and nitrogen doping),
surface termination, crystal size and, very importantly, to
micro-pattern the diamond surface by a range of methods
into biologically significant structures. Decades of research
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substrates known, thus adding one more property to the long
list of superlative characteristics of this material. The range of
potential uses for diamond in medicine is large, including:
blood vessel stents, microprobes, artificial joint components
and coatings for devices that would facilitate bone growth or
repair. Bioinert, but electrically conducting diamond films
can be used to make neural implants that can pass signals to
and from neurons in the brain, spine or peripheral nervous
system (hands, legs, fingers), withminimal inflammation, scar-
ring or signal loss. This offers the possibility of neural implants
with lifetimes of decades—potentially longer than that of the
patient—reducing the need for repeat surgeries and their
associated risks, complications and costs. Such advances
could usher in a new era in permanently implanted diamond
electrodes for treatments of a range of neurological diseases,
such as epilepsy, Parkinson’s, paralysis and even stroke.
Importantly, we are now at a stage where artificial
neuronal network technology is beginning to mature. Two-
dimensional networks of animal or human neurons can
now be created in the lab on a diamond substrate, where
the neurons follow predesigned patterns and grids, joining
at crossing points, and passing electrical signals between
each other and through the network as they would in a
living body. This is only possible because of the long lifetime
of the neurons on diamond compared to other substrates, and
made simpler by using the BDD substrate itself as a means to
send electrical stimuli into and out of the neural network.
Such two-dimensional neural networks may provide invalu-
able models with which neuroscientists could simulate the
more complex three-dimensional network of a brain. Another
benefit of these neural networks is that significant research
that would be too complicated, too expensive or too ethically
challenging to be carried out in vivo can now be performed invitro, in well-defined, reproducible conditions. These would
include genetic studies, age-related and degenerative disease
studies, investigation of neurotoxins, as well as performing
high-throughput screens for neurological drugs.
The future for diamond-based substrates and implants cer-
tainly looks promising; however, we should sound a note of
caution.Although it is relatively straightforward to obtain fund-
ing to develop end-user applications, such as the multinational
projects mentioned earlier, supported by governments and bio-
medical companies to make artificial retinas, bionic eyes and
other neuronal interfaces, there is the danger that these may
underperform due to a lack of understanding of the fundamen-
tal interface between diamond and cells. Obtaining funding to
study these basic questions is much more difficult, but without
it researchersmay find themselves trying to ‘run before they can
walk’. If the early bioimplants prove to have disappoint-
ing performance due to unexpected problems arising at the
diamond–cell interface, then this may prejudice the entire
case for using diamond in these applications. Hence, the
urgent need for governments, medical agencies, charities and
industry to fund the basic science underpinning the devices,
as well as the development of the devices themselves.
While only time can tell how sparkling the prospects for
diamond in the medical field might be, diamond is a material
that biologists, medical researchers and practitioners are
going to become increasingly familiar with.Data accessibility. This article has no additional data.
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